In a deal that will bolster its drug development capabilities, Biogen Idec has acquired a subsidiary of Swiss-based Neurimmune Holding AG.
Bristol-Myers Squibb has signed a definitive licensing pact with Oncolys BioPharma, a privately held Japanese biotech company, that will give it control of a promising new HIV treatment.
Abbott has made a pact with a biopharmaceutical company to develop new cancer treatments by making small-molecule inhibitors.
A healthcare accrediting organization is revising three products in its Pharmacy Quality Management suite of programs.
An Anglo-Swedish drug maker said it is discontinuing further development of a drug that is designed to prevent a respiratory virus that infects the lungs and breathing passages.
A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.
One month after announcing it would acquire a leader in molecular imaging development, Eli Lilly announced it has completed its acquisition of Avid Radiopharmaceuticals.
A Mylan subsidiary has settled a lawsuit brought on by the Department of Justice four years ago.
Drug makers King Pharmaceuticals and Acura Pharmaceuticals have submitted a regulatory approval application to the Food and Drug Administration for an opioid pain reliever.
Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.